{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:50:22Z","timestamp":1766040622662,"version":"3.48.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) is highly prevalent among individuals with type 2 diabetes mellitus (T2DM), and liver fibrosis represents its strongest predictor of adverse outcomes. Soft drinks (SDs), a major source of added sugars and fructose, have been linked to metabolic disorders, but evidence on their relationship with liver fibrosis in patients with T2DM is limited. This study investigated the association between SDs consumption and liver fibrosis in adults with both T2DM and liver steatosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 273 participants from the TESEO-DM cohort with imaging-documented hepatic steatosis (Controlled Attenuation Parameter, CAP \u2265248 dB\/m). SDs intake was assessed using the validated EPIC food frequency questionnaire and categorized as rarely\/never, 1\u20134 servings per month, or &amp;gt;1 servings per week. Liver stiffness measurement (LSM) was assessed using vibration-controlled transient elastography and LSM &amp;gt;7 used as cut-off to define significant liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In age- and sex-adjusted linear regression, SDs intake was directly associated with LSM (\u03b2 = 0.181, 95% CI: 0.062\u20130.299,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003). The association remained significant after adjustment for diabetes duration, total caloric intake, high-density lipoprotein cholesterol, and either body mass index (\u03b2 = 0.153, 95% CI: 0.032\u20130.274,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.014) or CAP (\u03b2 = 0.150; 95% CI: 0.028\u20130.274;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.017). In logistic regression, participants consuming &amp;gt;1 SDs per week had increased odds of significant liver fibrosis (OR: 3.77, 95% CI: 1.33\u201310.66) compared with those rarely or never consuming SDs independent of age, sex, diabetes duration, and obesity. Inclusion into the model of tertiles of CAP in place of obesity did not modify the results (OR: 3.11 95% CI: 1.09\u20138.86).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that even modest soft drink consumption is independently associated with higher liver stiffness in individuals with T2DM and liver steatosis, supporting recommendations to limit added sugar intake for liver health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2025.1726040","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:38Z","timestamp":1766040338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Soft drink consumption and liver fibrosis in type 2 diabetes"],"prefix":"10.3389","volume":"12","author":[{"given":"Arianna","family":"Ferro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Bollati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Caviglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Armandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selene","family":"Limoncelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Barutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo","family":"Beccuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Durazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Gruden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"54707","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","author":"Tacke","year":"2024","journal-title":"Obes Facts."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003493","article-title":"Effectiveness of a model of care based on fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study","author":"Caviglia","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/HEP.0000000000001015","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10654-020-00655-y","article-title":"Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies","volume":"35","author":"Qin","year":"2020","journal-title":"Eur J Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/ijcp.12841","article-title":"Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis","volume":"70","author":"Narain","year":"2016","journal-title":"Int J Clin Pract."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jamainternmed.2019.2478","article-title":"Association between soft drink consumption and mortality in 10 European countries","volume":"179","author":"Mullee","year":"2019","journal-title":"JAMA Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41387-023-00237-3","article-title":"Sugar-sweetened beverages, low\/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project","volume":"13","author":"Naomi","year":"2023","journal-title":"Nutr Diabetes."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/ajcn\/nqaa380","article-title":"Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin chronic low-grade systemic inflammation and health (TCLSIH) cohort study","volume":"113","author":"Zhang","year":"2021","journal-title":"Am J Clin Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.cgh.2021.05.052","article-title":"Sugar-sweetened beverages are associated with increased liver stiffness and steatosis among apparently healthy adults in the United States","volume":"20","author":"Leung","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B19","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort. European prospective investigation of cancer","volume":"80","author":"Day","year":"1999","journal-title":"Br J Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12102960","article-title":"Exploring the validity of the 14-item Mediterranean diet adherence screener (Medas): a cross-national study in seven European countries around the Mediterranean region","volume":"12","author":"Garc\u00eda-Conesa","year":"2020","journal-title":"Nutrients."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/HEP.0000000000000696","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.2337\/dc25-S010","article-title":"10. cardiovascular disease and risk management: standards of care in diabetes-\u22122025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.2337\/dc25-S011","article-title":"11. chronic kidney disease and risk management: standards of care in diabetes \u22122025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care."},{"key":"B25","unstructured":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","year":"2015","journal-title":"J Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1155\/2008\/810961","article-title":"Soft drink consumption linked with fatty liver in the absence of traditional risk factors","volume":"22","author":"Assy","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1186\/s12889-023-17223-0","article-title":"Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Public Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology."},{"key":"B32","unstructured":"Eurostat\n              Data Browser\n            \n          \n          Frequency of Drinking Sugar-Sweetened Soft Drinks by Sex, Age, and Educational Attainment Level\n          \n          2022"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1017\/S1368980021001580","article-title":"Trends and patterns in sugar-sweetened beverage consumption among children and adults by race and\/or ethnicity, 2003\u20132018","volume":"24","author":"Dai","year":"2021","journal-title":"Public Health Nutr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3390\/nu15143257","article-title":"Impact of chronotype and Mediterranean diet on the risk of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"15","author":"Castelnuovo","year":"2023","journal-title":"Nutrients."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3390\/nu15133018","article-title":"Impact of health related QoL and Mediterranean diet on liver fibrosis in patients with NAFLD","volume":"15","author":"Perez-Diaz-Del-Campo","year":"2023","journal-title":"Nutrients."},{"key":"B36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00394-025-03809-4","article-title":"Higher diet quality is associated with a lower prevalence of MASLD and adverse health outcomes: insights from NHANES 2005 to 2020","volume":"64","author":"Sualeheen","year":"2025","journal-title":"Eur J Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/HEP.0000000000000351","article-title":"Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"78","author":"Pennisi","year":"2023","journal-title":"Hepatology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1726040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:39Z","timestamp":1766040339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1726040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"alternative-id":["10.3389\/fnut.2025.1726040"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1726040","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1726040"}}